What's New and Different in the Surviving Sepsis Campaign 2026

Monday, March 23, 2026

9:45 AM - 10:45 AM Central Time

Location: Skyline Ballroom, W375ABC

Concurrent Session Moderator(s)

Craig Coopersmith, MD, MCCM (he/him/his)

Emory University Hospital, Georgia, AFG

Disclosure(s): No relevant financial relationship(s) to disclose.
Daniel Backer, Non-Member Physician

Chirec Hospitals, Belgium

Disclosure(s): Abott: Advisory Board (Ongoing); AOP pharma: Advisory Board (Ongoing); Pharmazz Inc.,: Advisory Board (Ongoing)

The Surviving Sepsis Campaign Guidelines updates will be released in 2026. This session will cover the guideline updates, the evidence behind them, and gaps in the research.

Learning Objectives:

Review Surviving Sepsis Campaign (SSC) methodology
Examine new and revised SSC recommendations
Discuss the application of SSC recommendations in low- and middle-income countries

Presentations:

9:50 AM - 10:05 AM Central Time

Key Aspects of Surviving Sepsis Campaign Methods
Waleed Alhazzani, MD, MSc, FRCPC – McMaster University
10:05 AM - 10:20 AM Central Time

New and Revised Surviving Sepsis Campaign Recommendations
Hallie Prescott, MD, MSc, FACP – University of Michigan
Massimo Antonelli, MD (he/him/his)
10:20 AM - 10:35 AM Central Time

Applicability of Surviving Sepsis Campaign to Low- and Middle-Income Countries
Mervyn Mer – Charlotte Maxeke Johannesburg Academic Hospital